Sell side is building up, sub $1 may be imminent while we are in limbo waiting to hear on FDA submission & CPT progress.
On a side note, Renalytix announced the below yesterday - looks like the fast tracked coverage that was anticipated to come with breakthrough device designation may not be an option for them anymore. I think this is good news to some extent, Richard has not made any mentions of PromarkerD applying for BDD so Renalytix had a slight advantage to get to market with this MCIT pathway. With this no longer being the case, it puts both parties in the same playing field having to submit their CPT code application to CMS for coverage.
PromarkerD $150 vs KidneyIntelX $950..
Looks positive for us IMO.
PIQ Price at posting:
$1.06 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)